Literature DB >> 10404805

Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia.

A Ferenczi1, M Garami, E Kiss, M Pék, M Sasvári-Székely, C Barta, M Staub, J Sólyom, G Fekete.   

Abstract

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders, causing impaired secretion of cortisol and aldosterone from the adrenal cortex, with subsequent overproduction of adrenal androgens. The most common enzyme defect causing CAH is steroid 21-hydroxylase deficiency. To determine the mutational spectrum in the Hungarian CAH population, the CYP21 active gene was analyzed using PCR. A total of 297 Hungarian patients with 21-hydroxylase deficiency are registered in the 2nd Department of Pediatrics, Budapest, Hungary, and their clinical status was evaluated. Blood samples for CYP21 genotype determination could be obtained from 167 patients (representing 306 unrelated chromosomes and 56.2% of the total group of patients). Eight of the most common mutations were screened [In2 (intron 2 splice mutation), I172N, Del (Del: apparents large gene conversion), Q318X, R356W, 1761Tins, ClusterE6, V281L] using allele-specific amplification. The most frequent mutation in the Hungarian CAH population was found to be In2. Our results have shown a good genotype/phenotype correlation in case of most mutations; the In2 mutation is associated mostly with the severe form of the disease, whereas I172N was expressed in a wide spectrum of phenotypes. 1999)

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404805     DOI: 10.1210/jcem.84.7.5835

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.

Authors:  Adina F Turcu; Juilee Rege; Robert Chomic; Jiayan Liu; Hiromi K Nishimoto; Tobias Else; Andreas G Moraitis; Ganesh S Palapattu; William E Rainey; Richard J Auchus
Journal:  J Clin Endocrinol Metab       Date:  2015-04-07       Impact factor: 5.958

2.  A large view of CYP21 locus among Sicilians and other populations: identification of a novel CYP21A2 variant in Sicily.

Authors:  M Niceta; M Bono; C Fabiano; F Pojero; F Niceta; P Sammarco; G Corsello; P Garofalo
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

3.  Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary.

Authors:  Dóra Török; Gudrun Eckhardt; János Sólyom
Journal:  Eur J Pediatr       Date:  2003-09-30       Impact factor: 3.183

4.  CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.

Authors:  Firdevs Baş; Hülya Kayserili; Feyza Darendeliler; Oya Uyguner; Hülya Günöz; Memnune Yüksel Apak; Fatmahan Atalar; Rüveyde Bundak; Robert C Wilson; Maria I New; Bernd Wollnik; Nurçin Saka
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-02-02

5.  Clinical profile and inheritance pattern of CYP21A2 gene mutations in patients with classical congenital adrenal hyperplasia from 10 families.

Authors:  Sarita Yadav; Shweta Birla; Eunice Marumudi; Arundhati Sharma; Rajesh Khadgawat; M L Khurana; A C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct

Review 6.  Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Authors:  Mahsa Kolahdouz; Zahra Mohammadi; Parisa Kolahdouz; Masoud Tajamolian; Hossein Khanahmad
Journal:  Adv Biomed Res       Date:  2015-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.